Compare Cell Therapeutics vs NGM Biopharmaceuticals
Customers evaluate the quality of Cell Therapeutics's products using the following success metrics.
Overview
Cell Therapeutics is 33 yrs old and is based in United States.
CTI is committed to developing, acquiring, and commercializing innovative treatments for cancer. In the company's pursuit of making cancer more treatable, they are developing a diversified portfolio of oncology products focused on identifying and developing new, less toxic, and more effective ways to treat cancer.
NGM Biopharmaceuticals is 16 yrs old and is based in United States.
NGM Biopharmaceuticals is a biopharmaceutical company with a focus on the discovery and development of novel medicines. The company's main offerings include the development of biologic drug candidates aimed at addressing large unmet medical needs in cancer and other diseases. The company primarily serves the healthcare and pharmaceutical industries. It was founded in 2008 and is based in South San Francisco, California.
Demo Video
Leadership
Craig W. Philips (President)
Jin-Long Chen (Founder)
Funding
Investors
EW Healthcare Partners, Cercano Management
Prospect Venture Partners, The Column Group
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cell Therapeutics has not claimed their profile.
Work for Cell Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cell Therapeutics?
Claim your profile now.
Information not available because NGM Biopharmaceuticals has not claimed their profile.
Work for NGM Biopharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for NGM Biopharmaceuticals?
Claim your profile now.